197 related articles for article (PubMed ID: 16290106)
21. Inhibition of NMDA-receptor mediated response in the rat medial prefrontal cortical pyramidal cells by the 5-HT3 receptor agonist SR 57227A and 5-HT: intracellular studies.
Liang X; Arvanov VL; Wang RY
Synapse; 1998 Jul; 29(3):257-68. PubMed ID: 9635896
[TBL] [Abstract][Full Text] [Related]
22. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
23. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats.
Tada K; Kasamo K; Ueda N; Suzuki T; Kojima T; Ishikawa K
J Pharmacol Exp Ther; 1999 Feb; 288(2):843-8. PubMed ID: 9918598
[TBL] [Abstract][Full Text] [Related]
24. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
Monti JM; Jantos H
Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
[TBL] [Abstract][Full Text] [Related]
25. Involvement of glutamate neurotransmission and N-methyl-d-aspartate receptor in the activation of midbrain dopamine neurons by 5-HT1A receptor agonists: an electrophysiological study in the rat.
Gronier B
Neuroscience; 2008 Oct; 156(4):995-1004. PubMed ID: 18801415
[TBL] [Abstract][Full Text] [Related]
26. Individual and additive effects of neuromodulators on the slow components of afterhyperpolarization currents in layer V pyramidal cells of the rat medial prefrontal cortex.
Satake T; Mitani H; Nakagome K; Kaneko K
Brain Res; 2008 Sep; 1229():47-60. PubMed ID: 18634769
[TBL] [Abstract][Full Text] [Related]
27. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
[TBL] [Abstract][Full Text] [Related]
28. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
[TBL] [Abstract][Full Text] [Related]
29. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
Li Z; Prus AJ; Dai J; Meltzer HY
J Pharmacol Exp Ther; 2009 Sep; 330(3):948-55. PubMed ID: 19491322
[TBL] [Abstract][Full Text] [Related]
31. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity.
Bortolozzi A; Díaz-Mataix L; Scorza MC; Celada P; Artigas F
J Neurochem; 2005 Dec; 95(6):1597-607. PubMed ID: 16277612
[TBL] [Abstract][Full Text] [Related]
32. Mu-opioid receptors in the ventral tegmental area are targeted to presynaptically and directly modulate mesocortical projection neurons.
Svingos AL; Garzón M; Colago EE; Pickel VM
Synapse; 2001 Sep; 41(3):221-9. PubMed ID: 11418935
[TBL] [Abstract][Full Text] [Related]
33. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
Navailles S; Moison D; Ryczko D; Spampinato U
J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
[TBL] [Abstract][Full Text] [Related]
34. Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
Nakayama K; Sakurai T; Katsu H
Brain Res Bull; 2004 Apr; 63(3):237-41. PubMed ID: 15145142
[TBL] [Abstract][Full Text] [Related]
35. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors.
Bermack JE; Debonnel G
J Psychopharmacol; 2007 Jan; 21(1):85-92. PubMed ID: 16533864
[TBL] [Abstract][Full Text] [Related]
36. Long-term reduction in ventral tegmental area dopamine neuron population activity following repeated stimulant or ethanol treatment.
Shen RY; Choong KC; Thompson AC
Biol Psychiatry; 2007 Jan; 61(1):93-100. PubMed ID: 16697354
[TBL] [Abstract][Full Text] [Related]
37. Differential involvement of ventral tegmental GABA(A) and GABA(B) receptors in the regulation of the nucleus accumbens dopamine response to stress.
Doherty M; Gratton A
Brain Res; 2007 May; 1150():62-8. PubMed ID: 17395162
[TBL] [Abstract][Full Text] [Related]
38. In vivo effects of pardoprunox (SLV308), a partial D₂/D₃ receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity.
Bétry C; Etiévant A; Lambás-Señas L; McCreary AC; Haddjeri N
Synapse; 2011 Oct; 65(10):1042-51. PubMed ID: 21446003
[TBL] [Abstract][Full Text] [Related]
39. Neural circuits engaged in ventral hippocampal modulation of dopamine function in medial prefrontal cortex and ventral striatum.
Taepavarapruk P; Howland JG; Ahn S; Phillips AG
Brain Struct Funct; 2008 Sep; 213(1-2):183-95. PubMed ID: 18288486
[TBL] [Abstract][Full Text] [Related]
40. Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.
Sato M; Ago Y; Koda K; Nakamura S; Kawasaki T; Baba A; Matsuda T
Eur J Pharmacol; 2007 Mar; 559(2-3):155-60. PubMed ID: 17258195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]